EP2267155A3 - Procédé de détection de mRNA du papillomavirus - Google Patents

Procédé de détection de mRNA du papillomavirus Download PDF

Info

Publication number
EP2267155A3
EP2267155A3 EP10184669A EP10184669A EP2267155A3 EP 2267155 A3 EP2267155 A3 EP 2267155A3 EP 10184669 A EP10184669 A EP 10184669A EP 10184669 A EP10184669 A EP 10184669A EP 2267155 A3 EP2267155 A3 EP 2267155A3
Authority
EP
European Patent Office
Prior art keywords
human papillomavirus
mrna
expression
detecting human
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10184669A
Other languages
German (de)
English (en)
Other versions
EP2267155B1 (fr
EP2267155A2 (fr
EP2267155B2 (fr
Inventor
Frank Karlsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norchip AS
Original Assignee
Norchip AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2267155(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0200239A external-priority patent/GB0200239D0/en
Priority claimed from GB0214124A external-priority patent/GB0214124D0/en
Application filed by Norchip AS filed Critical Norchip AS
Publication of EP2267155A2 publication Critical patent/EP2267155A2/fr
Publication of EP2267155A3 publication Critical patent/EP2267155A3/fr
Publication of EP2267155B1 publication Critical patent/EP2267155B1/fr
Application granted granted Critical
Publication of EP2267155B2 publication Critical patent/EP2267155B2/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP10184669.9A 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus Expired - Lifetime EP2267155B2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0200239A GB0200239D0 (en) 2002-01-07 2002-01-07 Method for detecting human papillomavirus mRNA
GB0214124A GB0214124D0 (en) 2002-06-19 2002-06-19 Method for detecting human papillomavirus mRNA
EP06075498.3A EP1715062B1 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP03700338A EP1463839B1 (fr) 2002-01-07 2003-01-07 Methode permettant de detecter l'arn messager du papillomavirus humain

Related Parent Applications (5)

Application Number Title Priority Date Filing Date
EP06075498.3A Division-Into EP1715062B1 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP06075498.3A Division EP1715062B1 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP03700338.1 Division 2003-01-07
EP03700338A Division EP1463839B1 (fr) 2002-01-07 2003-01-07 Methode permettant de detecter l'arn messager du papillomavirus humain
EP06075498.3 Division 2006-03-03

Publications (4)

Publication Number Publication Date
EP2267155A2 EP2267155A2 (fr) 2010-12-29
EP2267155A3 true EP2267155A3 (fr) 2011-06-08
EP2267155B1 EP2267155B1 (fr) 2013-03-13
EP2267155B2 EP2267155B2 (fr) 2016-09-07

Family

ID=26246916

Family Applications (5)

Application Number Title Priority Date Filing Date
EP10184464A Withdrawn EP2272988A3 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP10184669.9A Expired - Lifetime EP2267155B2 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP15158266.5A Expired - Lifetime EP2913407B1 (fr) 2002-01-07 2003-01-07 Procédé pour détecter l'arnm du papillomavirus humain
EP06075498.3A Expired - Lifetime EP1715062B1 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP03700338A Expired - Lifetime EP1463839B1 (fr) 2002-01-07 2003-01-07 Methode permettant de detecter l'arn messager du papillomavirus humain

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10184464A Withdrawn EP2272988A3 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus

Family Applications After (3)

Application Number Title Priority Date Filing Date
EP15158266.5A Expired - Lifetime EP2913407B1 (fr) 2002-01-07 2003-01-07 Procédé pour détecter l'arnm du papillomavirus humain
EP06075498.3A Expired - Lifetime EP1715062B1 (fr) 2002-01-07 2003-01-07 Procédé de détection de mRNA du papillomavirus
EP03700338A Expired - Lifetime EP1463839B1 (fr) 2002-01-07 2003-01-07 Methode permettant de detecter l'arn messager du papillomavirus humain

Country Status (20)

Country Link
US (4) US7553623B2 (fr)
EP (5) EP2272988A3 (fr)
JP (2) JP4558322B2 (fr)
CN (1) CN100422342C (fr)
AT (1) ATE354677T1 (fr)
AU (2) AU2003201639C1 (fr)
BR (1) BR0306723A (fr)
CA (1) CA2472026A1 (fr)
CY (1) CY1106621T1 (fr)
DE (1) DE60311961T2 (fr)
DK (2) DK1463839T3 (fr)
EA (1) EA006975B1 (fr)
ES (2) ES2654909T3 (fr)
IL (2) IL162722A0 (fr)
MX (1) MXPA04006440A (fr)
NO (1) NO20042769L (fr)
NZ (1) NZ533703A (fr)
PT (1) PT1463839E (fr)
SI (1) SI1463839T1 (fr)
WO (1) WO2003057914A2 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US20110111389A1 (en) * 2001-11-07 2011-05-12 Diagcor Bioscience Incorporation Limited Rapid genotyping analysis for human papillomavirus and the device thereof
EP2272988A3 (fr) 2002-01-07 2011-06-15 Norchip A/S Procédé de détection de mRNA du papillomavirus
EP1369694A1 (fr) * 2002-04-09 2003-12-10 MTM Laboratories AG Procédé de discrimination entre des métaplasies et des lésions néoplastiques ou préneoplastiques
EP1507148B1 (fr) * 2003-08-25 2005-02-23 MTM Laboratories AG Procédé de détection de carcinomes dans des échantillons corporels cervicaux solubilisés
ATE434167T1 (de) * 2003-03-07 2009-07-15 Univ New Jersey Med Optisch dekodierbare mikroträger, arrays und verfahren
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP1510820B1 (fr) * 2003-08-25 2010-03-17 MTM Laboratories AG Procédé pour la détection d'états médicalement pertinents dans des échantillons LBC solubilisés
JP4498357B2 (ja) * 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
WO2005033333A2 (fr) 2003-10-07 2005-04-14 Dako Denmark A/S Methodes et compositions pour le diagnostic de cancer
WO2005062940A2 (fr) 2003-12-22 2005-07-14 John Wayne Cancer Institute Procede et dispositif permettant de prelever et de surveiller in vivo la circulation de composants biologiques
GB0404315D0 (en) * 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus
ITMO20040126A1 (it) 2004-05-21 2004-08-21 Bioanalisi Ct Sud S N C Di Per Sistema per la ricerca ed identificazione di agenti patogeni
EP1809772B1 (fr) 2004-11-09 2013-06-05 Gen-Probe Incorporated Compositions et methode de detection de streptocoques du groupe a
ATE476528T1 (de) 2004-12-08 2010-08-15 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
EP3042963A1 (fr) 2005-06-20 2016-07-13 Advanced Cell Diagnostics, Inc. Procédés de détection d'acides nucléiques dans des cellules individuelles et d'identification de cellules rares dans de grandes populations cellulaires hétérogènes
CA2629564C (fr) * 2005-11-15 2014-04-22 Genoid Kft. Methode de detection de pathogenes
AU2006341730B2 (en) 2006-04-11 2013-04-11 Bio-Rad Innovations HPV detection and quantification by real-time multiplex amplification
US7833716B2 (en) * 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
US20100285443A1 (en) * 2006-12-15 2010-11-11 Oncomethylome Sciences Sa Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome
EP3095873B1 (fr) 2006-12-21 2018-04-18 Gen-Probe Incorporated Procédés et compositions pour l'amplification d'acide nucléiques
US7838215B2 (en) * 2007-09-25 2010-11-23 Canvir, Inc. Advanced cervical cell screening methods
JP5299986B2 (ja) * 2007-11-01 2013-09-25 国立大学法人山口大学 核酸の定量方法
CA2704151C (fr) 2007-11-01 2017-04-25 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Nouveau procede de detection de papillomavirus humains du col de l'uterus
JP2011518333A (ja) * 2008-04-17 2011-06-23 キアジェン ゲイサーズバーグ インコーポレイテッド 標的核酸の存在を判別するための合成プローブを用いた組成物、方法、およびキット
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
TWI419974B (zh) 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
EP2184368A1 (fr) 2008-11-07 2010-05-12 DKFZ Deutsches Krebsforschungszentrum Transcription de diagnostic et motifs d'épissage du HPV16 dans différentes lésions cervicales
AU2010242867B2 (en) * 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
EP2478087B1 (fr) * 2009-09-14 2017-01-18 QIAGEN Gaithersburg, Inc. Compositions et méthodes pour la récupération d'acides nucléiques ou de protéines à partir d'échantillons de tissus fixés dans des milieux de cytologie
US8722328B2 (en) * 2010-01-04 2014-05-13 Qiagen Gaithersburg, Inc. Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
JP2013517803A (ja) 2010-01-29 2013-05-20 キアジェン ゲイサーズバーグ インコーポレイテッド サンプル中のｈｐｖの存在を決定および確認する方法
WO2011094514A1 (fr) * 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Procédés et compositions pour la purification et l'analyse multiplexée d'acides nucléiques séquence-spécifique
US20110275698A1 (en) * 2010-05-10 2011-11-10 Norchip A/S "test and treat" strategy for treating transforming hpv infection
EP2572001A2 (fr) 2010-05-19 2013-03-27 QIAGEN Gaithersburg, Inc. Procédés et compositions pour purification séquence-spécifique et analyse multiplex d'acides nucléiques
CA2799205A1 (fr) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Analyse de capture hybride a resultats rapides et sondes associees tronquees de maniere strategique
ES2562821T3 (es) 2010-10-21 2016-03-08 Advanced Cell Diagnostics, Inc. Método ultrasensible para la detección in situ de ácidos nucleicos
CN103517994A (zh) * 2011-01-07 2014-01-15 奇亚根盖瑟斯堡股份有限公司 用于对高风险人乳头瘤病毒进行基因型分型和定量的材料和方法
CN103476948A (zh) * 2011-01-28 2013-12-25 领先细胞医疗诊断有限公司 用于测定头颈癌和宫颈病变中的hpv状态的rnascope* hpv测定法
EP2678442B1 (fr) 2011-02-24 2019-01-16 QIAGEN Gaithersburg, Inc. Matériels et procédés de détection d'acide nucléique de hpv
US20130095474A1 (en) * 2011-10-13 2013-04-18 Joseph Mamone Design of stem-loop probes and utilization in snp genotyping
WO2013067399A1 (fr) 2011-11-03 2013-05-10 Qiagen Gaithersburg, Inc. Substances et procédé pour immobiliser, isoler et concentrer des cellules en utilisant des surfaces carboxylées
CN102864224A (zh) * 2012-09-11 2013-01-09 南京大学 一种血清microRNAs试剂盒及其应用
GB201310933D0 (en) 2013-06-19 2013-07-31 Norchip As A method of cervical screening
CA2932859A1 (fr) * 2013-12-05 2015-06-11 Optipharm. Co., Ltd. Procede de diagnostic ameliore du cancer du col de l'uterus et kit de diagnostic associe
WO2016005789A1 (fr) 2014-07-07 2016-01-14 Institut Pasteur Transcriptome de papillomavirus à large spectre génétique et génotypique en tant que biomarqueur de stades du cancer associé à papillomavirus
CN106048014B (zh) * 2016-06-07 2019-12-10 博奥生物集团有限公司 一种用于实时检测nasba产物的高特异探针
US20190112673A1 (en) * 2017-05-10 2019-04-18 Genomic Vision Association between integration of high-risk hpv genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions
JP6831772B2 (ja) 2017-12-22 2021-02-17 株式会社Ｓｕｂａｒｕ 画像投影装置
CN114214343A (zh) * 2021-11-15 2022-03-22 上海市东方医院（同济大学附属东方医院） 一组高危型HPV整合所致的宫颈癌中特异表达的mRNA序列

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026934A2 (fr) * 1993-05-06 1994-11-24 Baxter Diagnostics Inc. Methode de detection du papillomavirus chez l'homme
EP0662518A2 (fr) * 1989-12-01 1995-07-12 Amoco Corporation Sonde d'acide nucléique pour détection des transcriptions du VPH
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
WO1999029890A2 (fr) * 1997-12-12 1999-06-17 Digene Corporation Evaluation de maladies liees au virus du papillome humain

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779175D1 (de) 1986-03-21 1992-06-25 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
WO1988006634A1 (fr) * 1987-02-26 1988-09-07 The University Of Sydney Procede de detection de papillomavirus humains carcinogenes
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
NL8900725A (nl) 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5506105A (en) * 1991-12-10 1996-04-09 Dade International Inc. In situ assay of amplified intracellular mRNA targets
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
EP0728218B1 (fr) 1993-11-12 2008-01-02 PHRI Properties, Inc. Sondes d'hybridation pour la detection d'acides nucleiques, souches universelles, methodes et materiels
DE19506561C1 (de) * 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
WO1997018334A2 (fr) 1995-11-15 1997-05-22 Gen-Probe Incorporated Sondes d'acides nucleiques complementaires des acides nucleiques du virus du papillome humain, methodes et preparations associees
US6027981A (en) 1997-10-27 2000-02-22 Texas Instruments - Acer Incorporated Method for forming a DRAM cell with a fork-shaped capacitor
WO2000000638A2 (fr) 1998-06-26 2000-01-06 Akzo Nobel N.V. Marquage d'amplicons d'arn produits au moyen d'une amplification fondee sur la transcription
WO2001073135A2 (fr) * 2000-03-28 2001-10-04 Biosearch International Pty. Ltd. Approches permettant de detecter et de classer hpv par stades par ciblage de la region du gene e6 du genome viral
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
GB0018050D0 (en) * 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
DK1421200T3 (da) * 2001-08-23 2007-04-10 Merck & Co Inc Fluoprescerende multiplex HPV PCR-assays under anvendelse af flere fluoroforer
GB0200258D0 (en) * 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
EP2272988A3 (fr) 2002-01-07 2011-06-15 Norchip A/S Procédé de détection de mRNA du papillomavirus
GB0404315D0 (en) * 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662518A2 (fr) * 1989-12-01 1995-07-12 Amoco Corporation Sonde d'acide nucléique pour détection des transcriptions du VPH
WO1994026934A2 (fr) * 1993-05-06 1994-11-24 Baxter Diagnostics Inc. Methode de detection du papillomavirus chez l'homme
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
WO1999029890A2 (fr) * 1997-12-12 1999-06-17 Digene Corporation Evaluation de maladies liees au virus du papillome humain

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOSCH F X ET AL: "PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL CANCER: A WORLDWIDE PERSPECTIVE", JOURNAL OF THE NATIONAL CANCER INSTITUTE, OXFORD UNIVERSITY PRESS, GB, vol. 87, no. 11, 7 June 1995 (1995-06-07), pages 796 - 802, XP008017322, ISSN: 0027-8874, DOI: 10.1093/JNCI/87.11.796 *
MUÑOZ N: "Human papillomavirus and cancer: the epidemiological evidence.", JOURNAL OF CLINICAL VIROLOGY : THE OFFICIAL PUBLICATION OF THE PAN AMERICAN SOCIETY FOR CLINICAL VIROLOGY OCT 2000 LNKD- PUBMED:11091143, vol. 19, no. 1-2, October 2000 (2000-10-01), pages 1 - 5, XP002633297, ISSN: 1386-6532 *
SCHNEIDER A., HOYER H., DÜRST M.: "Bedeutung des Nachweises von humanen Papillomviren für die Vorsorge", DEUTSCHES ÄRTZEBLATT, vol. 98, no. 39, 28 September 2001 (2001-09-28), pages A2517 - A2521, XP002633298 *
SMITS H L ET AL: "APPLICATION OF THE NASBA NUCLEIC ACID AMPLIFICATION METHOD FOR THE DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 E6-E7 TRANSCRIPTS", JOURNAL OF VIROLOGICAL METHODS, AMSTERDAM, NL, vol. 54, no. 1, 1995, pages 75 - 81, XP009015131, ISSN: 0166-0934 *

Also Published As

Publication number Publication date
US7553623B2 (en) 2009-06-30
PT1463839E (pt) 2007-05-31
JP5204132B2 (ja) 2013-06-05
EP1715062A2 (fr) 2006-10-25
US20090275044A1 (en) 2009-11-05
US20090253124A1 (en) 2009-10-08
EP1715062A3 (fr) 2007-07-11
ES2282599T3 (es) 2007-10-16
SI1463839T1 (sl) 2007-08-31
EA200400919A1 (ru) 2005-02-24
CY1106621T1 (el) 2012-01-25
EP2267155B1 (fr) 2013-03-13
IL162722A (en) 2013-09-30
DE60311961T2 (de) 2007-10-18
EP2913407B1 (fr) 2017-11-01
DE60311961D1 (de) 2007-04-05
US7812144B2 (en) 2010-10-12
EP1715062B1 (fr) 2015-03-11
EP2272988A2 (fr) 2011-01-12
EP1463839B1 (fr) 2007-02-21
AU2003201639B2 (en) 2008-05-15
WO2003057914A2 (fr) 2003-07-17
JP2005514038A (ja) 2005-05-19
MXPA04006440A (es) 2005-03-31
EP2913407A1 (fr) 2015-09-02
AU2008205436A1 (en) 2008-09-04
EP2267155A2 (fr) 2010-12-29
JP2010131020A (ja) 2010-06-17
BR0306723A (pt) 2004-12-21
NO20042769L (no) 2004-10-04
JP4558322B2 (ja) 2010-10-06
EA006975B1 (ru) 2006-06-30
NZ533703A (en) 2006-05-26
US20050118568A1 (en) 2005-06-02
ES2654909T3 (es) 2018-02-15
DK2913407T3 (en) 2018-01-15
HK1065827A1 (en) 2005-03-04
EP1463839A2 (fr) 2004-10-06
EP2272988A3 (fr) 2011-06-15
DK1463839T3 (da) 2007-07-02
AU2003201639C1 (en) 2009-02-26
US8420314B2 (en) 2013-04-16
AU2003201639A1 (en) 2003-07-24
IL162722A0 (en) 2005-11-20
ATE354677T1 (de) 2007-03-15
CN100422342C (zh) 2008-10-01
US20130309658A1 (en) 2013-11-21
CN1639357A (zh) 2005-07-13
EP2267155B2 (fr) 2016-09-07
WO2003057914A3 (fr) 2004-02-26
CA2472026A1 (fr) 2003-07-17

Similar Documents

Publication Publication Date Title
EP1715062A3 (fr) Procédé de détection de mRNA du papillomavirus
WO2004079014A3 (fr) Signatures de statut er d'un cancer du sein
EP1975665A3 (fr) Lentille d'imagerie et appareil d'imagerie
WO2006075245A3 (fr) Systemes, methodes et compositions pour la detection de papillomavirus humain dans des echantillons biologiques
AU2003288556A1 (en) Scoring estrogen and progesterone receptors expression based on image analysis
WO2005098037A8 (fr) Signatures du cancer du sein
WO2004045455A3 (fr) Plaques vissées déformables
MXPA05012202A (es) Aparato y metodo que proporciona informacion de ubicacion.
WO2006063065A3 (fr) Detection d'acides nucleiques de types multiples de papillomavirus humains
EP2258877A3 (fr) Dosage d'ARNm de E6, E7 HPV et méthodes d'utilisation associées
EP2249155A3 (fr) Marqueur du cancer
EP2144201A3 (fr) Appareil et procédé de traitement d'images
WO2002008460A3 (fr) Procede de detection d'arnm de papillomavirus humain
EP2465525A3 (fr) Cellules NKT élevées et leurs utilisations dans le traitement de troubles liés à l'immunité
AU2003284701A1 (en) Method of examining blood type and apparatus for examining blood type using the method.
WO2003023056A3 (fr) Marqueurs specifiques a la sclerose en plaques
WO2010033619A3 (fr) Systèmes, procédés, et compositions permettant de détecter le virus à papillome humain dans des échantillons biologiques
AU3205600A (en) Method and kit for early cancer prediction
AU2002347226A1 (en) Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit
WO2006096224A3 (fr) Procede de detection simultanee d'arn et d'adn de papillomavirus humain dans un echantillon
EP1314787A3 (fr) Le gène Midkine est associé au cancer
EP1465058A3 (fr) Procédé et appareil pour la multiplication modulaire
DE602006009117D1 (de) Verfahren zur identifizierung von die stresstoleranz in hefe erhöhenden genen sowie verwendung dieser gene zur verbesserung von hefestämmen
AU2003295246A1 (en) In vitro diagnosis method for early detection of cervical dysplasias and cancer, associated with hpv
AU2003294932A1 (en) Method for the detection of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 1715062

Country of ref document: EP

Kind code of ref document: P

Ref document number: 1463839

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

17P Request for examination filed

Effective date: 20111208

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 1463839

Country of ref document: EP

Kind code of ref document: P

Ref document number: 1715062

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 600857

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130315

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60343534

Country of ref document: DE

Effective date: 20130508

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130624

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130613

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 600857

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130313

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20130313

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130614

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130715

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: BECKMAN COULTER, INC.

Effective date: 20131212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

REG Reference to a national code

Ref country code: DE

Ref legal event code: R026

Ref document number: 60343534

Country of ref document: DE

Effective date: 20131212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

PLAF Information modified related to communication of a notice of opposition and request to file observations + time limit

Free format text: ORIGINAL CODE: EPIDOSCOBS2

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140107

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140131

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140107

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: BECKMAN COULTER, INC.

Effective date: 20131212

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130313

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20030107

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20160907

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R102

Ref document number: 60343534

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20220118

Year of fee payment: 20

Ref country code: DE

Payment date: 20220124

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20220114

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60343534

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20230106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20230106